The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of BridgeBio Pharma Inc (NASDAQ: BBIO) closed at $25.03 in the last session, down -1.69% from day before closing price of $25.46. In other words, the price has decreased by -$1.69 from its previous closing price. On the day, 1.54 million shares were traded. BBIO stock price reached its highest trading level at $25.78 during the session, while it also had its lowest trading level at $24.44.
Ratios:
We take a closer look at BBIO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.32 and its Current Ratio is at 3.32.
On January 31, 2024, BMO Capital Markets started tracking the stock assigning a Market Perform rating and target price of $37.
On December 08, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $58.Wells Fargo initiated its Overweight rating on December 08, 2023, with a $58 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 01 ’24 when Scott Randal W. sold 2,500 shares for $34.00 per share. The transaction valued at 85,000 led to the insider holds 6,500 shares of the business.
Valantine Hannah sold 2,915 shares of BBIO for $110,041 on Feb 15 ’24. The Director now owns 1,764 shares after completing the transaction at $37.75 per share. On Jan 16 ’24, another insider, Valantine Hannah, who serves as the Director of the company, sold 2,915 shares for $37.97 each. As a result, the insider received 110,683 and left with 1,764 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BBIO now has a Market Capitalization of 4690621952 and an Enterprise Value of 5717739520. For the stock, the TTM Price-to-Sale (P/S) ratio is 496.43. Its current Enterprise Value per Revenue stands at 614.612 whereas that against EBITDA is -9.643.
Stock Price History:
Over the past 52 weeks, BBIO has reached a high of $44.32, while it has fallen to a 52-week low of $12.75. The 50-Day Moving Average of the stock is -17.04%, while the 200-Day Moving Average is calculated to be -18.54%.
Shares Statistics:
According to the various share statistics, BBIO traded on average about 1.69M shares per day over the past 3-months and 1728910 shares per day over the past 10 days. A total of 175.08M shares are outstanding, with a floating share count of 138.83M. Insiders hold about 24.73% of the company’s shares, while institutions hold 71.52% stake in the company. Shares short for BBIO as of 1711584000 were 14280874 with a Short Ratio of 8.45, compared to 1709164800 on 13636078. Therefore, it implies a Short% of Shares Outstanding of 14280874 and a Short% of Float of 12.189999.
